These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 20050717

  • 1. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S, Hazra A, Ghosh M.
    Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717
    [Abstract] [Full Text] [Related]

  • 2. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
    Molina JD, Toledo-Romero F, López-Rodríguez E, Amorin-Díaz M, Lerma-Carrillo I, López-Muñoz F.
    Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
    Mortimer A, Martin S, Lôo H, Peuskens J, SOLIANOL Sudy Group.
    Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
    Martin S, Lĵo H, Peuskens J, Thirumalai S, Giudicelli A, Fleurot O, Rein W, SOLIANOL Study Group.
    Curr Med Res Opin; 2002 Mar; 18(6):355-62. PubMed ID: 12442883
    [Abstract] [Full Text] [Related]

  • 5. A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
    Vanelle JM, Douki S.
    Eur Psychiatry; 2006 Dec; 21(8):523-30. PubMed ID: 17113759
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
    Genç Y, Taner E, Candansayar S.
    Adv Ther; 2007 Dec; 24(1):1-13. PubMed ID: 17526456
    [Abstract] [Full Text] [Related]

  • 7. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
    Wagner M, Quednow BB, Westheide J, Schlaepfer TE, Maier W, Kühn KU.
    Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006
    [Abstract] [Full Text] [Related]

  • 8. The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
    Lecrubier Y, Quintin P, Bouhassira M, Perrin E, Lancrenon S.
    Acta Psychiatr Scand; 2006 Nov; 114(5):319-27. PubMed ID: 17022791
    [Abstract] [Full Text] [Related]

  • 9. Practical issues with amisulpride in the management of patients with schizophrenia.
    Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.
    Clin Drug Investig; 2008 Nov; 28(8):465-77. PubMed ID: 18598092
    [Abstract] [Full Text] [Related]

  • 10. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR, Sampson S, Li BG, Zhao S, Xia J, Furtado VA.
    Cochrane Database Syst Rev; 2016 Jul 02; 7(7):CD010832. PubMed ID: 27370402
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
    Chabannes JP, Pelissolo A, Farah S, Gerard D.
    Encephale; 1998 Jul 02; 24(4):386-92. PubMed ID: 9809244
    [Abstract] [Full Text] [Related]

  • 12. Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
    Hofer A, Rettenbacher MA, Edlinger M, Huber R, Bodner T, Kemmler G, Sachs G, Fleischhacker WW.
    Pharmacopsychiatry; 2007 Jan 02; 40(1):1-8. PubMed ID: 17327953
    [Abstract] [Full Text] [Related]

  • 13. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S.
    Int J Neuropsychopharmacol; 2004 Mar 02; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [Abstract] [Full Text] [Related]

  • 14. A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
    Lee SJ, Lee JH, Jung SW, Koo BH, Choi TY, Lee KH.
    Clin Drug Investig; 2012 Nov 02; 32(11):735-45. PubMed ID: 23018281
    [Abstract] [Full Text] [Related]

  • 15. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM, Glick ID, Weiden PJ, Romano SJ, Siu CO.
    Am J Psychiatry; 2004 Oct 02; 161(10):1837-47. PubMed ID: 15465981
    [Abstract] [Full Text] [Related]

  • 16. Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
    Peuskens J, De Hert M, Mortimer A, SOLIANOL Study Group.
    Int Clin Psychopharmacol; 2007 May 02; 22(3):145-52. PubMed ID: 17414740
    [Abstract] [Full Text] [Related]

  • 17. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
    Johnsen E, Kroken RA, Løberg EM, Rettenbacher M, Joa I, Larsen TK, Reitan SK, Walla B, Alisauskiene R, Anda LG, Bartz-Johannessen C, Berle JØ, Bjarke J, Fathian F, Hugdahl K, Kjelby E, Sinkeviciute I, Skrede S, Stabell L, Steen VM, Fleischhacker WW.
    Lancet Psychiatry; 2020 Nov 02; 7(11):945-954. PubMed ID: 33069317
    [Abstract] [Full Text] [Related]

  • 18. Clinical update on amisulpride in deficit schizophrenia.
    Rein W, Turjanski S.
    Int Clin Psychopharmacol; 1997 May 02; 12 Suppl 2():S19-27. PubMed ID: 9218164
    [Abstract] [Full Text] [Related]

  • 19. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.
    BMC Psychiatry; 2005 Jan 13; 5():3. PubMed ID: 15649317
    [Abstract] [Full Text] [Related]

  • 20. Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
    Linden M, Eich FX, Pyrkosch L.
    Int Clin Psychopharmacol; 2007 May 13; 22(3):175-8. PubMed ID: 17414744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.